Q2 2010

Filed Aug 16, 2010 · 10-Q · 47 days after period end · 0000950123-10-078110

Q2 2010 · 10-Q

Revenue

$10.74M

no prior Q2 2009 on file

Net Income

$287.30K

no prior Q2 2009 on file

EPS Diluted

$0.01

no prior Q2 2009 on file

Operating Income$1,009,860—

Margins · derived

Same quarter

no prior Q2 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Jun 30, 2010 · filed Aug 16, 2010 · 47 d after period end

Cumberland Pharmaceuticals Inc · CIK 1087294 · Engraved from SEC EDGAR